Curated by the JDD Editors
Missed any of our May highlights? May is our Skin Health issue and is packed with intriguing articles, and you’ll want to start to dive in! Catch up with this curated roundup from the JDD Editors. This is your guide to must-read articles for the derm community.
Longer Pembrolizumab Therapy Reduces Mortality in Stage III and IV Melanoma: A TriNetX Study evaluates whether longer durations of pembrolizumab therapy improve overall mortality in stage III and stage IV melanoma.
Efficacy and Safety of Cosibelimab for Advanced Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel suggests that cosibelimab is an effective treatment for patients with laCSCC and mCSCC who are not candidates for surgery or radiation.
The Emerging Role of Metformin in Skin Cancer: Mechanistic and Clinical Insights discusses how mechanistic and preclinical data support a biologically plausible role for metformin in skin cancer prevention and therapy.
Efficacy and Safety of Topical Metformin vs Kligman Formula in the Treatment of Melasma: A Split-Face Study shares the results of when participants applied the formulas to different sides of the face at bedtime.
Dermatologists’ Practices and Perspectives on Human Papillomavirus, Surgical Plume, and Cancer Risk reveals a disconnect between procedural exposure and consistent protective practices among dermatologists
Pembrolizumab as an Off-Label Treatment of Facial Angiosarcoma: A Case Report showcases an atypical case of cutaneous angiosarcoma presenting as unilateral nasal swelling in an elderly male.
